NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Sees Significant Drop in Short Interest

NeuroOne Medical Technologies Co. (NASDAQ:NMTC) was the recipient of a large drop in short interest in January. As of January 15th, there was short interest totalling 70,300 shares, a drop of 37.1% from the December 31st total of 111,800 shares. Currently, 0.3% of the company’s shares are short sold. Based on an average daily volume of 173,400 shares, the days-to-cover ratio is currently 0.4 days.

NeuroOne Medical Technologies Price Performance

NeuroOne Medical Technologies stock traded up $0.14 during midday trading on Wednesday, reaching $1.29. The stock had a trading volume of 48,894 shares, compared to its average volume of 287,264. The firm’s fifty day simple moving average is $0.86 and its two-hundred day simple moving average is $0.86. NeuroOne Medical Technologies has a twelve month low of $0.55 and a twelve month high of $1.59. The firm has a market cap of $39.87 million, a price-to-earnings ratio of -2.84 and a beta of 0.41.

NeuroOne Medical Technologies (NASDAQ:NMTC) last issued its earnings results on Tuesday, December 17th. The company reported ($0.11) EPS for the quarter. NeuroOne Medical Technologies had a negative net margin of 356.76% and a negative return on equity of 407.04%.

Institutional Trading of NeuroOne Medical Technologies

An institutional investor recently bought a new position in NeuroOne Medical Technologies stock. XTX Topco Ltd bought a new stake in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 26,408 shares of the company’s stock, valued at approximately $26,000. XTX Topco Ltd owned about 0.09% of NeuroOne Medical Technologies at the end of the most recent quarter. Institutional investors and hedge funds own 16.07% of the company’s stock.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.